Correlation Between Rocket Pharmaceuticals and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rocket Pharmaceuticals and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rocket Pharmaceuticals and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rocket Pharmaceuticals and Akero Therapeutics, you can compare the effects of market volatilities on Rocket Pharmaceuticals and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rocket Pharmaceuticals with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rocket Pharmaceuticals and Akero Therapeutics.
Diversification Opportunities for Rocket Pharmaceuticals and Akero Therapeutics
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rocket and Akero is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Rocket Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rocket Pharmaceuticals are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Rocket Pharmaceuticals i.e., Rocket Pharmaceuticals and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Rocket Pharmaceuticals and Akero Therapeutics
Given the investment horizon of 90 days Rocket Pharmaceuticals is expected to under-perform the Akero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Rocket Pharmaceuticals is 1.3 times less risky than Akero Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Akero Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 5,166 in Akero Therapeutics on August 31, 2024 and sell it today you would lose (1,956) from holding Akero Therapeutics or give up 37.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rocket Pharmaceuticals vs. Akero Therapeutics
Performance |
| Timeline |
| Rocket Pharmaceuticals |
| Akero Therapeutics |
Rocket Pharmaceuticals and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rocket Pharmaceuticals and Akero Therapeutics
The main advantage of trading using opposite Rocket Pharmaceuticals and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rocket Pharmaceuticals position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Rocket Pharmaceuticals vs. Uniqure NV | Rocket Pharmaceuticals vs. Rhythm Pharmaceuticals | Rocket Pharmaceuticals vs. Solid Biosciences LLC | Rocket Pharmaceuticals vs. MeiraGTx Holdings PLC |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |